Product Code: ETC312104 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Bahrain Aminoglycosides Market is projected to witness mixed growth rate patterns during 2025 to 2029. Growth accelerates to 2.08% in 2027, following an initial rate of 1.35%, before easing to 1.03% at the end of the period.
The Aminoglycosides market in Bahrain is projected to grow at a stable growth rate of 2.08% by 2027, highlighting the country's increasing focus on advanced technologies within the Middle East region, where Saudi Arabia holds the dominant position, followed closely by United Arab Emirates, Iran, Qatar and Kuwait, shaping overall regional demand.
The Aminoglycosides Market in Bahrain, covering a class of antibiotics such as gentamicin and streptomycin, remains vital for the healthcare sector. These antibiotics are essential for treating severe bacterial infections and are in demand in both human and veterinary medicine. The market is shaped by hospital procurement and regulatory controls on antibiotic stewardship.
The market for aminoglycosides in Bahrain is influenced by ongoing demand in treating bacterial infections resistant to conventional antibiotics. However, trends show a cautious use due to toxicity concerns, prompting healthcare providers to rely on these drugs primarily in hospital settings. Research into less nephrotoxic derivatives and combination therapies is shaping future applications.
The aminoglycosides market in Bahrain, which includes antibiotics like gentamicin and streptomycin, is limited by a small healthcare market and restrictive regulations around antibiotic usage. Rising antimicrobial resistance concerns have led to tighter controls on prescription and distribution, thereby impacting demand. Additionally, the public health sector dominates pharmaceutical procurement, and price-sensitive tendering practices can limit the introduction of premium or newer aminoglycoside formulations. Import dependence and long regulatory lead times add further complexities to market growth.
As a class of antibiotics, aminoglycosides are crucial in treating bacterial infections. Bahrains healthcare sector offers potential for investors to import high-quality generics, partner with pharmaceutical distributors, or collaborate with healthcare institutions to ensure proper antimicrobial stewardship and secure medical supply chains.
Aminoglycoside antibiotics are vital in treating severe infections and are commonly used in both human and animal medicine. Bahrains Ministry of Health ensures access to WHO-recommended essential medicines, including aminoglycosides. Imports are tightly regulated for efficacy and resistance monitoring, in line with global antibiotic stewardship efforts. In the veterinary space, government policies focus on responsible use, supporting awareness campaigns and tracking systems under the Ministry of Municipalities Affairs and Agriculture. Local formulation is encouraged for essential antibiotics, backed by research and funding initiatives.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bahrain Aminoglycosides Market Overview |
3.1 Bahrain Country Macro Economic Indicators |
3.2 Bahrain Aminoglycosides Market Revenues & Volume, 2021 & 2031F |
3.3 Bahrain Aminoglycosides Market - Industry Life Cycle |
3.4 Bahrain Aminoglycosides Market - Porter's Five Forces |
3.5 Bahrain Aminoglycosides Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Bahrain Aminoglycosides Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Bahrain Aminoglycosides Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Bahrain Aminoglycosides Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Bahrain |
4.2.2 Growing awareness about the effectiveness of aminoglycosides in treating severe infections |
4.2.3 Rising investments in healthcare infrastructure in Bahrain |
4.3 Market Restraints |
4.3.1 Stringent regulations related to antibiotic use and prescription in Bahrain |
4.3.2 Rising concerns about antibiotic resistance and adverse effects of aminoglycosides |
5 Bahrain Aminoglycosides Market Trends |
6 Bahrain Aminoglycosides Market, By Types |
6.1 Bahrain Aminoglycosides Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Bahrain Aminoglycosides Market Revenues & Volume, By Product, 2021 - 2031F |
6.1.3 Bahrain Aminoglycosides Market Revenues & Volume, By Neomycin, 2021 - 2031F |
6.1.4 Bahrain Aminoglycosides Market Revenues & Volume, By Tobramycin, 2021 - 2031F |
6.1.5 Bahrain Aminoglycosides Market Revenues & Volume, By Gentamicin, 2021 - 2031F |
6.1.6 Bahrain Aminoglycosides Market Revenues & Volume, By Amikacin, 2021 - 2031F |
6.1.7 Bahrain Aminoglycosides Market Revenues & Volume, By Paromomycin, 2021 - 2031F |
6.1.8 Bahrain Aminoglycosides Market Revenues & Volume, By Streptomycin, 2021 - 2031F |
6.1.9 Bahrain Aminoglycosides Market Revenues & Volume, By Others, 2021 - 2031F |
6.1.10 Bahrain Aminoglycosides Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Bahrain Aminoglycosides Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Bahrain Aminoglycosides Market Revenues & Volume, By Injectables (Parenteral), 2021 - 2031F |
6.2.3 Bahrain Aminoglycosides Market Revenues & Volume, By Feed, 2021 - 2031F |
6.2.4 Bahrain Aminoglycosides Market Revenues & Volume, By Intra-mammary, 2021 - 2031F |
6.2.5 Bahrain Aminoglycosides Market Revenues & Volume, By Topical, 2021 - 2031F |
6.2.6 Bahrain Aminoglycosides Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3 Bahrain Aminoglycosides Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Bahrain Aminoglycosides Market Revenues & Volume, By Veterinary, 2021 - 2031F |
6.3.3 Bahrain Aminoglycosides Market Revenues & Volume, By Skin Infection, 2021 - 2031F |
6.3.4 Bahrain Aminoglycosides Market Revenues & Volume, By Respiratory diseases, 2021 - 2031F |
6.3.5 Bahrain Aminoglycosides Market Revenues & Volume, By UTI & Pelvic Diseases, 2021 - 2031F |
6.3.6 Bahrain Aminoglycosides Market Revenues & Volume, By Other diseases, 2021 - 2031F |
7 Bahrain Aminoglycosides Market Import-Export Trade Statistics |
7.1 Bahrain Aminoglycosides Market Export to Major Countries |
7.2 Bahrain Aminoglycosides Market Imports from Major Countries |
8 Bahrain Aminoglycosides Market Key Performance Indicators |
8.1 Rate of adoption of aminoglycosides in hospitals and healthcare facilities in Bahrain |
8.2 Number of clinical trials evaluating new applications or formulations of aminoglycosides in Bahrain |
8.3 Average length of hospital stay for patients treated with aminoglycosides in Bahrain |
9 Bahrain Aminoglycosides Market - Opportunity Assessment |
9.1 Bahrain Aminoglycosides Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Bahrain Aminoglycosides Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Bahrain Aminoglycosides Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Bahrain Aminoglycosides Market - Competitive Landscape |
10.1 Bahrain Aminoglycosides Market Revenue Share, By Companies, 2024 |
10.2 Bahrain Aminoglycosides Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |